The United States officials have granted approval for the first long-acting drug that offers protection against a respiratory virus that poses a significant threat to babies and toddlers, sending a large number of American children to the hospital every year. Respiratory Syncytial Virus (RSV) is typically a minor inconvenience for most healthy individuals, resembling a common … [Read more...] about First Long-Acting Drug Approved by FDA to Protect Infants and Toddlers from Respiratory Virus
Footer
